Nachrichten zur AstraZeneca PLC Aktie

Im Biotech-Sektor vergeht derzeit gefühlt keine Handelswoche ohne die Ankündigung einer Übernahme im Wert von über einer Milliarde Dollar. Vor…

Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…

Der britische Pharmakonzern Astrazeneca hat den Kauf der chinesischen Firma Gracell Biotechnologies verkündet, um sein Engagement im Bereich der Krebsimmuntherapie…

LONDON (dpa-AFX) - Astrazeneca will sich mit einem Zukauf im Bereich der zunehmend wichtigen Zelltherapien…

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 13000…

AstraZeneca PLC (LSE:AZN) is set to acquire Gracell Biotechnologies, the Chinese company specialising in innovative cancer and autoimmune disease...…

ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy"…

27 December 2023 AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases Includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic…

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.…

Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…

…

…

…

…

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases…

Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Injection Pen Market: Analysis By Type, By Therapy, By…

22 December 2023 Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated…

Ionis Pharmaceuticals and AstraZenecas Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of…

FDA approves Ionis (IONS) and partner AstraZenecas (AZN) Wainua for treating ATTRv-PN. Ionis stock rises on this important milestone.…

FDA approves AstraZeneca (AZN) and Ionis (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Mercks chronic cough candidate, gefapixant.…

Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis,…

For investors, the focus in 2024 will be on navigating a year expected to be split into distinct halves. That,…

Assemblin has been commissioned to perform and coordinate multidisciplinary technical installations in the areas of electricity, ventilation, cooling and heating…

Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.…

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added…

Nacka, Sweden, December 14, 2023: Atlas Copco Group has appointed Christina Malmberg Hägerstrand as its new Media Relations Manager. Christina Malmberg…

Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources are part of the Zacks top Analyst Blog.…

…

Der Pharmakonzern AstraZeneca erweitert Produktportfolio durch den Zukauf von Icosavax für einen Milliardenbetrag. Hannover Rück hebt die Wachstumsziele für die…

Für bis zu 1,1 Milliarden US-Dollar übernimmt AstraZeneca das US-Biopharma-Unternehmen Icosavax. Damit will Astrazeneca seine Impfstoff- und Immuntherapien-Pipeline ...…

The gastroesophageal reflux disease market is expected to show positive growth, mainly attributed to increased prevalence and the expected launch…

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…

Vaccines specialist Icosavax Inc (NASDAQ: ICVX) is set to surge 45% on Tuesday after agreeing to be taken over by Anglo-Swedish…

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…

In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to acquire U.S. vaccine…

…

…

AstraZeneca to buy U.S.-based Icosavax for up to $1.1 billion…

…

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca…

News Release Regulatory News Service 12 December 2023 AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase…

The company has secured multiple new agreements since it bought AstraZenecas 580,000-square-foot West Chester facility.…

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Icosavax, for a total deal value of up to $1.1 billion.…

…

Itll take a few years for its latest moves to pay off, assuming they do.…

In our Newsletter published on 7TH December 2023, a section was included related to AstraZeneca BioVentureHub. This was not officially…

By John Vandermosten, CFA NASDAQ:ALLR Early Results - Phase II Stenoparib Allarity Therapeutics, Inc. (NASDAQ:ALLR) provided an update to investors on its…

The Global Artificial Intelligence In Precision Medicine Market Size was valued at USD 1.28 Billion in 2022 and the Global…